The purpose of this study is to evaluate the effectiveness of the medication levodopa, in
combination with speech-language treatment, on the language outcome of study subjects with
nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and
written language) following a stroke.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Rehabilitation Institute of Chicago Shirley Ryan AbilityLab